Review
Open access
Jul 2026
The future of TCR-Treg therapies is renewables.
This review highlights emerging solutions for closed, automated and decentralised production, and discusses allogeneic approaches using gene-edited or banked Tregs with HLA engineering or matching with potential to provide safe, affordable tolerance-restoring therapies for autoimmune disease.
Cheng Rui Peh, T. Nguyen-Dumont, Y. Ting et al.
· Autoimmunity Reviews · 2 citations